
Publication|Articles|April 7, 2026
- Re-adding EXPAREL to Formulary: The Pharmacist Perspective
Re-adding EXPAREL to Formulary: The Pharmacist Perspective
Author(s)Pacira Pharmaceuticals, Inc.
Key Takeaways
This article is sponsored by Pacira Pharmaceuticals, Inc.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Enlicitide, the First Oral PCSK9 Inhibitor for High Cholesterol
2
Bringing Bispecific Therapy Into the Outpatient Community Oncology Setting
3
Brain Imaging Study Links Long COVID to Dopamine Neuron Injury, Pointing to Repurposed Treatments
4
PPI, Antibiotic Exposure Associated With Attenuated Immunotherapy Benefit in Stage 3 NSCLC
5






































































































